Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4539788
Max Phase: Preclinical
Molecular Formula: C35H42N6O5S
Molecular Weight: 658.82
Molecule Type: Unknown
Associated Items:
ID: ALA4539788
Max Phase: Preclinical
Molecular Formula: C35H42N6O5S
Molecular Weight: 658.82
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1cc(S(=O)(=O)N2CCCC2)ccc1-c1ccc(C[C@H](NC(=O)[C@H]2CC[C@H](CN)CC2)C(=O)Nc2ccc3c(=O)[nH][nH]c3c2)cc1
Standard InChI: InChI=1S/C35H42N6O5S/c1-22-18-28(47(45,46)41-16-2-3-17-41)13-15-29(22)25-8-4-23(5-9-25)19-32(38-33(42)26-10-6-24(21-36)7-11-26)35(44)37-27-12-14-30-31(20-27)39-40-34(30)43/h4-5,8-9,12-15,18,20,24,26,32H,2-3,6-7,10-11,16-17,19,21,36H2,1H3,(H,37,44)(H,38,42)(H2,39,40,43)/t24-,26-,32-/m0/s1
Standard InChI Key: YKEUPPOASIWEHM-BAMJFLLESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 658.82 | Molecular Weight (Monoisotopic): 658.2937 | AlogP: 4.05 | #Rotatable Bonds: 10 |
Polar Surface Area: 170.25 | Molecular Species: BASE | HBA: 6 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.76 | CX Basic pKa: 10.40 | CX LogP: 3.79 | CX LogD: 1.91 |
Aromatic Rings: 4 | Heavy Atoms: 47 | QED Weighted: 0.17 | Np Likeness Score: -1.23 |
1. Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA.. (2020) Fibrinolysis Inhibitors: Potential Drugs for the Treatment and Prevention of Bleeding., 63 (4): [PMID:31658420] [10.1021/acs.jmedchem.9b01060] |
Source(1):